great question.
I don't think Lilly would care for ACR as they are too big and probably spend 50x more on their R&D than ACR standalone, I see Mayne Pharma as a company that might find ACR interesting as they are partially competing in the same topical space.
Also I would have thought ACR would have been far more attractive 2 years ago when it had 30+ million in bank, maybe Dobinson got a call from a potential suitor but like always he was asleep at the wheel.
CEO has great pharma connections so if a suitor was around he would know about it.
- Forums
- ASX - By Stock
- takeover target
ACR
acrux limited
Add to My Watchlist
5.00%
!
1.9¢

great question.I don't think Lilly would care for ACR as they...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $7.747M |
Open | High | Low | Value | Volume |
2.0¢ | 2.0¢ | 1.9¢ | $13.72K | 687.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 618035 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 618035 | 0.019 |
3 | 381800 | 0.018 |
3 | 472000 | 0.017 |
1 | 66732 | 0.015 |
1 | 70000 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 10000 | 1 |
0.021 | 177000 | 1 |
0.022 | 27574 | 2 |
0.023 | 115126 | 4 |
0.024 | 306848 | 8 |
Last trade - 14.19pm 18/06/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
The Watchlist
CDE
CODEIFAI LIMITED
John Houston / Martin Ross, Executive Chairman / COO
John Houston / Martin Ross
Executive Chairman / COO
Previous Video
Next Video
SPONSORED BY The Market Online